Amarantus Bioscience Holdings, Inc.
company.status.inactiveCIK 1424812fmd_1CR789X6ADCQXS124RPG9H469PManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 14, 2008 to Mar 31, 2016, 26 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | – | – | – |
| Net interest income | – | – | – | (1) | (2) | – | – | – |
| Research and development | – | – | 0 | 1 | 1 | 2 | 14 | 13 |
| Total operating expenses | – | – | – | – | 4 | 6 | 21 | 25 |
| Operating income | – | – | (1) | (4) | (4) | (6) | (21) | (25) |
| Interest expense | – | – | (0) | (1) | 2 | 3 | 1 | 2 |
| Interest and investment income | – | – | 0 | (1) | (1) | – | – | – |
| Other non-operating income (expense) | – | – | – | – | (1) | (9) | (6) | (0) |
| Income before taxes | – | – | – | – | (5) | (15) | (27) | (25) |
| Income tax expense | – | – | – | – | 0 | 0 | 0 | – |
| Net income from continuing operations | – | – | – | – | (5) | (15) | (27) | – |
| Net income | (0) | (0) | (1) | (4) | (5) | (15) | (27) | (25) |
| Net income to common shareholders | – | – | – | – | (5) | (15) | (28) | (37) |